Dan Leonard
Stock Analyst at UBS
(4.76)
Main Sectors:
Top Industries:
36 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
GH Guardant Health | Maintains: Strong Buy | 70 80 | 60.03 | 33.27% | 10 | Sep 25, 2025 | |
TXG 10x Genomics | Maintains: Neutral | 12 13 | 11.72 | 10.92% | 6 | Aug 8, 2025 | |
EXAS Exact Sciences | Maintains: Neutral | 61 53 | 53.57 | -1.06% | 10 | Aug 7, 2025 | |
CERT Certara | Maintains: Buy | 18 15 | 11.8 | 27.12% | 10 | Aug 7, 2025 | |
MEDP Medpace Hldgs | Downgrades: Sell | 300 305 | 496.79 | -38.61% | 2 | Jul 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 460 500 | 464.24 | 7.7% | 17 | Jul 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 240 225 | 184.84 | 21.73% | 15 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 185 225 | 179.5 | 25.35% | 16 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 1530 1350 | 1204.26 | 12.1% | 9 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 95 70 | 51.85 | 35% | 11 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 57 45 | 31.04 | 44.97% | 11 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 355 310 | 271.15 | 14.33% | 20 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 115 | 84.05 | 36.82% | 2 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 122 99 | 92.78 | 6.7% | 1 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 25 | 11.85 | 110.97% | 7 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 250 185 | 148.58 | 24.51% | 6 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 9 | 9.2 | -2.17% | 2 | Oct 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 22.59 | 54.94% | 4 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 150 | 123.41 | 21.55% | 20 | Aug 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 200 | 91.69 | 118.13% | 16 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 11 | 2.82 | 290.07% | 6 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 70 | 162.97 | -57.05% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 7 | 13.22 | -47.05% | 2 | Feb 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 160 | n/a | n/a | 12 | Feb 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 345 | 291.75 | 18.25% | 12 | Aug 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 260 | 163.79 | 58.74% | 5 | Aug 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 1 | n/a | n/a | 3 | Aug 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 160 145 | 188.98 | -23.27% | 10 | Feb 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 90 | 67.21 | 33.91% | 12 | Feb 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 62 64 | 43.9 | 44.99% | 2 | Dec 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 330 340 | 280.67 | 21.14% | 11 | Dec 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 24 | 25.72 | -6.69% | 1 | Aug 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 4 2 | n/a | n/a | 3 | May 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 45 35 | 7.7 | 354.55% | 11 | Aug 14, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 80 55 | n/a | n/a | 3 | May 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | 18 0 | n/a | n/a | 3 | May 7, 2018 |